BLOG / 🇺🇸 United States · · daily

High-Value Federal Grants ($5M+) — September 09, 2026

High-Value Federal Grants ($5M+)

By Gunpowder Editorial ·

2 total filings analysed

Executive Summary

The two high-value civilian contracts totaling $218 million present a bifurcated investment story: a robust, cash-flow-positive $110.6 million DHS/CBP award to Astrophysics Inc. for border security inspection systems, and a mature, non-competitive $107.4 million HHS Employee Assistance Program contract to Magellan Healthcare Inc. that is nearing its 2022 end date.

The dominant theme is civilian agency spending on stable, non-defense services and niche technology, with no defense exposure. The highest-conviction signal is Astrophysics Inc.'s 84% outlay rate ($92.8M funded), indicating strong execution and predictable near-term cash flows, but the key risk is the firm-fixed-price structure on the Astrophysics contract, which could compress margins if maintenance costs exceed estimates. Magellan's non-competitive award provides a long-term revenue stream but introduces re-competition risk and low technology differentiation.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from September 08, 2026.

Investment Signals (2)

  • Astrophysics Inc. Secures $110.6M DHS Border Security Contract with Strong Execution (HIGH)

    The $110.6 million firm-fixed-price delivery order for low-energy non-intrusive inspection systems is 84% outlayed ($92.8M), signaling strong contract execution and cash flow visibility through 2027 with potential extension to 2033.

  • Magellan Healthcare Inc.'s $107.4M HHS Contract Nears Expiration with Re-Competition Uncertainty (MEDIUM)

    The $107.4 million non-competitive Employee Assistance Program contract ends in December 2022, with only $13.2M outlayed against the total, creating re-competition risk and potential revenue loss for Magellan Healthcare.

Risk Flags (3)

  • Execution [MEDIUM RISK]

    Astrophysics Inc.'s $110.6M firm-fixed-price contract carries medium pricing risk; if maintenance costs on the inspection systems exceed estimates, margins could be compressed over the long performance period through 2027.

  • Competition [HIGH RISK]

    Magellan Healthcare Inc.'s $107.4M HHS contract was awarded non-competitively but expires in December 2022; a re-competition could introduce new entrants and pressure pricing or result in loss of the contract.

  • Concentration [MEDIUM RISK]

    Both contracts are civilian (0% defense), exposing investors to potential budget cuts or continuing resolution impacts on non-defense discretionary spending, particularly DHS border technology and HHS employee services.

Opportunities (2)

  • Astrophysics Inc.'s $110.6M DHS contract has a potential end date of 2033, offering a long-term revenue runway; follow-on orders or modifications for additional inspection systems could expand the contract value.

  • Magellan Healthcare Inc.'s non-competitive $107.4M HHS award suggests a strong incumbent position; if the contract is extended or renewed without competition, it could signal a durable relationship and stable revenue.

Sector Themes (2)

  • The $110.6M Astrophysics Inc. contract for non-intrusive inspection systems highlights sustained DHS/CBP spending on advanced detection technology, a niche but growing area within homeland security.

  • The $107.4M Magellan Healthcare Inc. HHS contract, awarded non-competitively and nearing its 2022 end, exemplifies the risk in long-term civilian services contracts that face re-competition and potential margin compression.

Watch List (3)

  • 👁

    {"entity" => "Astrophysics Inc.", "reason" => "The $110.6M DHS contract is 84% outlayed; any follow-on orders or modifications will signal continued revenue growth and execution momentum.", "trigger" => "Contract modification or new delivery order announcement from DHS/CBP"}

  • 👁

    {"entity" => "Magellan Healthcare Inc.", "reason" => "The $107.4M HHS contract expires in December 2022; re-competition or extension will determine near-term revenue stability.", "trigger" => "HHS solicitation for Employee Assistance Program re-compete or contract extension filing"}

  • 👁

    {"entity" => "Civilian services sector ETFs", "reason" => "Both contracts are civilian; prolonged continuing resolution or budget cuts to non-defense agencies could pressure the sector.", "trigger" => "CR enactment or FY2027 budget proposal with civilian agency reductions"}

Get daily alerts with 2 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 2 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: High-Value Federal Grants ($5M+)

🇺🇸 More from United States

View all →